Headache and Migraine

>

Latest News

Atogepant Safe, Effective in Treatment-Resistant Episodic Migraine: Daily Dose / image credit: ©New Africa/AdobeStock
Atogepant Safe, Effective in Treatment-Resistant Episodic Migraine: Daily Dose

March 4th 2024

Your daily dose of the clinical news you may have missed.

Atogepant Safe and Effective in Treatment-Resistant Episodic Migraine: ELEVATE Phase 3b Trial / image credit woman with headache: ©nataletado/stock.adobe.com
Atogepant Safe and Effective in Treatment-Resistant Episodic Migraine: ELEVATE Phase 3b Trial

February 27th 2024

Migraine-Related Stigma Impacts Quality of Life: Daily Dose / image credit: ©New Africa/AdobeStock
Migraine-Related Stigma Impacts Quality of Life: Daily Dose

February 5th 2024

Migraine-related Stigma is Common and Impacts Level of Disability, Quality of Life image credit woman in pain: ©itsmejust/stock.adobe.com
Migraine-related Stigma is Common and Impacts Level of Disability, Quality of Life

January 25th 2024

Motor Vehicle Crashes 3 Times More Likely Among Older Adults with New Migraine Diagnosis  / image credit older woman ©Aletia2011/stock.adobe.com
Older Adults with New Onset Migraine 3 Times More Likely to Have Motor Vehicle Accident

January 5th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.